Literature DB >> 23529909

Mitochondrial disease: a challenge for the caregiver, the family, and society.

Kalliopi Sofou1.   

Abstract

Mitochondrial diseases represent a genetically and clinically heterogeneous group of inherited metabolic disorders, often resulting in poor functional and survival outcomes for the patient and considerable psychosocial distress for the caregiver. The systematic review undertaken in the present paper emphasizes the critical role of the caregiver in the management of a child with mitochondrial disease, with focus on the burden of mitochondrial disease on the caregiver, the family, and society.

Entities:  

Mesh:

Year:  2013        PMID: 23529909     DOI: 10.1177/0883073813481622

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  6 in total

1.  Sea food consumption for improving cardiac and cerebral manifestations of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes.

Authors:  Fulvio A Scorza; Josef Finsterer
Journal:  Ann Transl Med       Date:  2017-09

2.  PARP inhibition delays progression of mitochondrial encephalopathy in mice.

Authors:  Roberta Felici; Leonardo Cavone; Andrea Lapucci; Daniele Guasti; Daniele Bani; Alberto Chiarugi
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

3.  Blended cognitive behaviour therapy for children and adolescents with mitochondrial disease targeting fatigue (PowerMe): study protocol for a multiple baseline single case experiment.

Authors:  I L Klein; K F E van de Loo; T J Hoogeboom; M C H Janssen; J A M Smeitink; E van der Veer; C M Verhaak; J A E Custers
Journal:  Trials       Date:  2021-03-01       Impact factor: 2.279

Review 4.  Recent advances in mitochondrial diseases: From molecular insights to therapeutic perspectives.

Authors:  Ahmad M Aldossary; Essam A Tawfik; Mohammed N Alomary; Samar A Alsudir; Ahmed J Alfahad; Abdullah A Alshehri; Fahad A Almughem; Rean Y Mohammed; Mai M Alzaydi
Journal:  Saudi Pharm J       Date:  2022-05-28       Impact factor: 4.562

5.  Mitochondrial disease patient motivations and barriers to participate in clinical trials.

Authors:  Zarazuela Zolkipli-Cunningham; Rui Xiao; Amy Stoddart; Elizabeth M McCormick; Amy Holberts; Natalie Burrill; Shana McCormack; Lauren Williams; Xiaoyan Wang; John L P Thompson; Marni J Falk
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

6.  Psychological functioning in children suspected for mitochondrial disease: the need for care.

Authors:  Kim F E van de Loo; José A E Custers; Saskia Koene; Inge-Lot Klein; Mirian C H Janssen; Jan A M Smeitink; Christianne M Verhaak
Journal:  Orphanet J Rare Dis       Date:  2020-03-24       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.